Core Viewpoint - The article discusses the contrasting outcomes of two IPOs on the Sci-Tech Innovation Board, highlighting the approval of Hengkun New Materials and the deferral of Taijin New Energy's IPO, emphasizing regulatory scrutiny on future performance stability and revenue recognition policies [1][3][5]. Group 1: IPO Outcomes - Hengkun New Materials successfully passed its second review on August 29, 2023, with no major inquiries raised during the meeting, leading to a swift registration submission on the same day [3]. - Taijin New Energy, on the other hand, faced a "deferred review" during its first meeting, marking it as the second IPO this year to encounter such a situation [5][8]. Group 2: Regulatory Concerns - The regulatory body focused on two main issues during Taijin New Energy's review: the risk of significant future performance decline and the accuracy of revenue recognition timing [5][9]. - Taijin New Energy's revenue and net profit have shown growth over the past three years, but concerns about future performance stability have arisen due to various factors affecting business stability [8][9]. Group 3: Business Performance and Adjustments - Taijin New Energy's fundraising plan was reduced from 1.5 billion to 990 million yuan, eliminating the supplementary working capital project, with the new funds allocated to two industrialization projects and a research center [8]. - The company reported a decline in order amounts in 2024 compared to previous years, alongside a decrease in customer sales growth, raising concerns about the stability of its business operations [9].
又一家IPO暂缓审议 泰金新能业绩会否大幅下滑被重点关注
Sou Hu Cai Jing·2025-09-01 15:08